Endo International PLC (ENDP) News
Filter ENDP News Items
ENDP News Results
|Loading, please wait...|
ENDP News Highlights
- ENDP's 30 day story count now stands at 19.
- Over the past 11 days, the trend for ENDP's stories per day has been choppy and unclear. It has oscillated between 1 and 10.
- DRUG, PD and CFR are the most mentioned tickers in articles about ENDP.
Latest ENDP News From Around the Web
Below are the latest news stories about ENDO INTERNATIONAL PLC that investors may wish to consider to help them evaluate ENDP as an investment opportunity.
Endo Luxembourg Finance I Company S.a.r.l. -- Moody's downgrades Endo's PDR to D-PD following Chapter 11 filing
Rating Action: Moody's downgrades Endo's PDR to D-PD following Chapter 11 filingGlobal Credit Research - 19 Aug 2022New York, August 19, 2022 -- Moody's Investors Service ("Moody's") downgraded Endo Luxembourg Finance I Company S.a.r.l., and other subsidiaries of Endo International plc (together, "Endo") Probability of Default Rating (PDR) to D-PD from Ca-PD following company's filing for protection under Chapter 11 of the US Bankruptcy Code on August 16th. Moody's affirmed Endo's all other ratings including the Corporate Family Rating (CFR) at Caa3, the company's senior secured debt at Caa2, the secured 2nd Lien Regular Bond/Debenture at Ca, and the unsecured ratings at C. Concurrently, Moody's downgraded Speculative Grade Liquidity Rating to SGL-4 from SGL-3. At current levels of pe...
The pharmaceutical company, which filed for Chapter 11 bankruptcy protection, had the 320,000-square-foot complex built a decade ago.
TJX Companies (TJX) stock is on the move Wednesday after releasing mixed results in its earnings report for Q2 of fiscal 2023.
Endo International (ENDP) stock is taking a beating on Wednesday after the company filed for bankruptcy protection and revealed an RSA.
We've got the news behind the biggest pre-market stock movers for Wednesday morning that traders need to know about this morning!
A federal judge in Cleveland awarded $650 million in damages Wednesday to two Ohio counties that won a landmark lawsuit against national pharmacy chains CVS, Walgreens and Walmart, claiming the way they distributed opioids to customers caused severe harm to communities and created a public nuisance.
Endo International became the latest pharmaceutical company to file for bankruptcy under the weight of lawsuits alleging it played a role in fueling the opioid crisis.
The pharmaceutical company, which has its U.S. headquarters in Malvern, currently has debts totaling $8 billion.
Endo (ENDP) finally files for bankruptcy after negotiations with its debtholders as litigation claims continue to weigh on the business.
The generic drugmaker Endo International which faces thousands of lawsuits related to its alleged role in the opioid crisis, filed for bankruptcy late Tuesday morning, while announcing a plan to sell itself through a process administered by the bankruptcy court. As part of its plan, Endo (ticker: ENDP) secured an agreement from creditors to acquire the firm through a $6 billion credit bid. Other potential buyers could make higher offers through a process the company will ask the bankruptcy court to administer.